MG
ATEX icon

Michael Gelband’s Anterix ATEX Stock Holding History

Michael Gelband’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,794
Closed -$336K – 1568
2026
Q1 		$336K Buy
+8,794
New +$278K ﹤0.01% 1291
2025
Q2 		– Sell
-26,983
Closed -$988K – 1456
2025
Q1 		$988K Sell
26,983
-51,448
-66% -$1.77M 0.01% 924
2024
Q4 		$2.4M Buy
+78,431
New +$2.61M 0.02% 654
2024
Q3 		– Sell
-56,325
Closed -$2.23M – 1609
2024
Q2 		$2.23M Buy
+56,325
New +$1.82M 0.02% 739
2023
Q4 		– Sell
-11,469
Closed -$360K – 1459
2023
Q3 		$360K Buy
11,469
+1,408
+14% +$44.3K ﹤0.01% 1358
2023
Q2 		$319K Buy
+10,061
New +$325K ﹤0.01% 1516
2020
Q4 		– Sell
-11,930
Closed -$390K – 1946
2020
Q3 		$390K Sell
11,930
-18,414
-61% -$780K 0.01% 1148
2020
Q2 		$1.38M Buy
+30,344
New +$1.55M 0.04% 583

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $2.34B AUM 46.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PM
Plustick Management Charlottesville, Virginia $269M AUM 340.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Michael Gelband's ATEX Position: Q2 2026 in Review

Michael Gelband sold out of Anterix (ATEX) in Q2 2026, closing a stake of 8,794 shares — an estimated $336K sold.

Michael Gelband first reported a position in ATEX in Q2 2020 and held it in 8 quarters. The position peaked at $2.4M in Q4 2024. 171 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Michael Gelband reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 8,794 Anterix shares in Q2 2026, an estimated $336K.
  • Michael Gelband first reported a position in Anterix in Q2 2020 and held it in 8 quarters.
  • Michael Gelband's Anterix position peaked at $2.4M in Q4 2024.
  • 171 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.